13F reference period
Q3 2026
Security Snapshot
Prestige Consumer Healthcare Inc. - Common Stock SH (PBH) Institutional Ownership
CUSIP: 74112D101
13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026
Institutions Reporting
188
Shares (Excl. Options)
28.58M
Full value: 28,583,730 · shares · 30 Sep 2026Price
$45.87
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock SH
- Symbol
- PBH on NYSE
- All holders as of 30 Sep 2026
- Q3 2026
- Total 13F shares
- 28,583,730
- Total 13F value
- $1,312,849,160
- Portfolio coverage rank
- 0%
- Share change
- +1,200,902
- Value change
- +$55,031,911
- Number of holders
- 188
- Shares outstanding
- 47,269,039
- SEC-reported price per share
- $48.50
- Insider filing price
- $48.50
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- PBH - Prestige Consumer Healthcare Inc. - Common Stock SH is tracked under CUSIP 74112D101.
- 188 institutions reported positions in Q3 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 317 to 188 between Q2 2026 and Q3 2026.
- SEC-reported value moved from to
$2.54B
Full value: $2,544,088,407 · USD · 30 Jun 2026.$1.31B
Full value: $1,312,849,160 · USD · 30 Sep 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 188 institutions filings for Q3 2026.
Security key
74112D101
13F reference period
Q3 2026
13F holders
188
13D/G owners
6
CIK / CUSIP context first
Open Q3 2026 holders
PBH full holder history
Prestige Consumer Healthcare Inc. SEC filings
Prestige Consumer Healthcare Inc. company facts
Prestige Consumer Healthcare Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74112D101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
PBH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | $609,115,318 | 7,524,587 | BlackRock, Inc. | 31 Mar 2025 | |||
| ARIEL INVESTMENTS, LLC | 10% | +20% | $230,162,470 | +$36,221,847 | 4,868,711 | +19% | Ariel Investments, LLC | 30 Jun 2026 |
| DIMENSIONAL FUND ADVISORS LP | 5.9% | $235,326,993 | 2,907,066 | Dimensional Fund Advisors LP | 31 Dec 2024 | |||
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6% | $167,528,789 | 2,826,536 | Vanguard Portfolio Management | 31 Mar 2026 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.2% | $145,506,309 | 2,454,974 | Vanguard Capital Management | 31 Mar 2026 | |||
| MACQUARIE GROUP LTD | 4.7% | $186,914,926 | 2,309,017 | Macquarie Group Limited | 31 Dec 2024 |
As of 30 Sep 2026,
188
institutional investors reported holding
shares of
Prestige Consumer Healthcare Inc. - Common Stock SH (PBH).
This represents
60%
of the company’s total
outstanding shares.
28.58M
Full value: 28,583,730 · shares · 30 Sep 202647.27M
Full value: 47,269,039 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
55%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARIEL INVESTMENTS, LLC | 11% | 4,975,958 | +2.2% | 2.4% | $228,247,194 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.9% | 2,810,363 | -0.53% | 0.01% | $128,911,351 |
| DIMENSIONAL FUND ADVISORS LP | 5.6% | 2,649,545 | -0.44% | 0.02% | $121,537,038 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 5.3% | 2,527,139 | +8.4% | 0.34% | $115,919,883 |
| STATE STREET CORP | 4.7% | 2,210,977 | +4.5% | 0% | $101,417,515 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 2,145,420 | +0.4% | 0% | $98,410,415 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7% | 1,286,756 | -18% | 0% | $59,032,362 |
| MORGAN STANLEY | 2.7% | 1,268,606 | +2% | 0% | $58,191,045 |
| NORDEA INVESTMENT MANAGEMENT AB | 1.7% | 823,872 | -0.57% | 0.03% | $38,351,241 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1.5% | 706,926 | +7.3% | 0.03% | $32,426,696 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.4% | 662,497 | +5.2% | 0.01% | $30,388,738 |
| Invesco Ltd. | 1.1% | 541,592 | +33% | 0% | $24,842,825 |
| Leeward Investments, LLC - MA | 1.1% | 526,609 | +20% | 1.2% | $24,155,555 |
| RAYMOND JAMES FINANCIAL INC | 1% | 491,685 | +5.9% | 0.01% | $22,553,589 |
| VANGUARD FIDUCIARY TRUST CO | 0.68% | 320,441 | +2.1% | 0% | $14,698,629 |
| MARSHALL WACE, LLP | 0.66% | 309,635 | +898% | 0.01% | $14,202,959 |
| Tributary Capital Management, LLC | 0.6% | 283,688 | +12% | 1.2% | $13,012,769 |
| Boston Trust Walden Corp | 0.58% | 272,292 | -55% | 0.1% | $12,490,034 |
| Public Sector Pension Investment Board | 0.54% | 256,905 | +58% | 0.03% | $12,614,036 |
| CONGRESS ASSET MANAGEMENT CO | 0.35% | 163,834 | 0.05% | $7,515,066 | |
| Edgestream Partners, L.P. | 0.34% | 159,212 | +2225% | 0.2% | $7,303,054 |
| Fisher Asset Management, LLC | 0.33% | 158,339 | -36% | 0% | $7,263,049 |
| NICHOLAS COMPANY, INC. | 0.32% | 150,970 | +0.03% | 0.13% | $6,924,994 |
| FIRST TRUST ADVISORS LP | 0.29% | 135,423 | +117% | 0% | $6,211,852 |
| Clearbridge Investments, LLC | 0.24% | 112,487 | +0.14% | 0% | $5,159,779 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 28,583,730 | $1,312,849,160 | +$55,031,911 | $45.87 | 188 |
| 2026 Q2 | 53,761,748 | $2,544,088,407 | +$42,828,096 | $47.27 | 317 |
| 2026 Q1 | 51,965,194 | $3,076,558,524 | +$20,318,471 | $59.27 | 353 |
| 2025 Q4 | 51,625,462 | $3,184,309,811 | -$39,666,152 | $61.69 | 354 |
| 2025 Q3 | 50,810,480 | $3,171,948,668 | -$74,667,802 | $62.40 | 351 |
| 2025 Q2 | 52,028,208 | $4,154,947,022 | +$68,664,201 | $79.85 | 372 |
| 2025 Q1 | 51,179,850 | $4,399,098,887 | -$94,834,306 | $85.97 | 354 |
| 2024 Q4 | 52,470,130 | $4,096,580,344 | +$88,611,492 | $78.09 | 335 |
| 2024 Q3 | 51,041,422 | $3,683,307,685 | +$3,200,629 | $72.10 | 323 |
| 2024 Q2 | 51,067,584 | $3,515,715,953 | -$4,889,638 | $68.85 | 305 |
| 2024 Q1 | 51,320,692 | $3,722,982,898 | +$23,075,777 | $72.56 | 311 |
| 2023 Q4 | 51,115,027 | $3,129,318,451 | +$6,370,695 | $61.22 | 287 |
| 2023 Q3 | 50,946,303 | $2,913,995,592 | +$55,643,279 | $57.19 | 279 |
| 2023 Q2 | 49,864,351 | $2,965,000,913 | -$29,425,137 | $59.43 | 273 |
| 2023 Q1 | 50,365,220 | $3,154,009,517 | +$46,802,032 | $62.63 | 280 |
| 2022 Q4 | 50,007,293 | $3,131,794,375 | +$2,107,559 | $62.60 | 286 |
| 2022 Q3 | 50,088,729 | $2,496,799,721 | -$37,445,090 | $49.83 | 270 |
| 2022 Q2 | 50,591,595 | $2,974,240,060 | +$45,867,050 | $58.80 | 273 |
| 2022 Q1 | 50,360,901 | $2,667,571,389 | -$38,075,618 | $52.94 | 269 |
| 2021 Q4 | 50,531,110 | $3,065,040,827 | -$86,724,122 | $60.65 | 261 |
| 2021 Q3 | 50,742,397 | $2,847,713,877 | -$66,715,011 | $56.11 | 240 |
| 2021 Q2 | 51,943,459 | $2,706,851,067 | -$30,851,217 | $52.10 | 219 |
| 2021 Q1 | 52,622,155 | $2,319,703,648 | +$13,619,119 | $44.08 | 233 |
| 2020 Q4 | 52,481,635 | $1,830,396,086 | -$33,067,279 | $34.87 | 227 |
| 2020 Q3 | 53,391,500 | $1,942,255,015 | -$69,442,046 | $36.42 | 233 |